2018-2025 Hemophilia A Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 123 pages | ID: 2B46CE0251FEN
QYResearch

Abstracts

SUMMARY

This report studies the Hemophilia A Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Hemophilia A Drug market by product type and application/end industries.

The global Hemophilia A Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hemophilia A Drug.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Hemophilia A Drug in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Bayer AG
• BioMarin Pharmaceutical Inc
• Bioverativ Inc
• Catalyst Biosciences Inc
• Chugai Pharmaceutical Co Ltd
• CSL Ltd
• DBV Technologies SA
• Dimension Therapeutics Inc
• EpiVax Inc
• Expression Therapeutics LLC
• Green Cross Corp
• Idogen AB
• Immusoft Corp
• LFB SA
• mAbxience SA

On the basis of product, the market is primarily split into

• ATXF-8117
• BAY-1093884
• BIVV-001
• BS-027125
• Concizumab
• CSL-689
• Others

On the basis on the end users/application, this report covers

• Clinic
• Hospital
• ASCs

Contents

2018-2025 HEMOPHILIA A DRUG REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 HEMOPHILIA A DRUG MARKET OVERVIEW

2.1 Hemophilia A Drug Product Overview
2.2 Hemophilia A Drug Market Segment by Type
  2.2.1 ATXF-8117
  2.2.2 BAY-1093884
  2.2.3 BIVV-001
  2.2.4 BS-027125
  2.2.5 Concizumab
  2.2.6 CSL-689
  2.2.7 Others
2.3 Global Hemophilia A Drug Product Segment by Type
  2.3.1 Global Hemophilia A Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Hemophilia A Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Hemophilia A Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Hemophilia A Drug Price (USD/Pcs) by Type (2013-2018)
2.4 United States Hemophilia A Drug Product Segment by Type
  2.4.1 United States Hemophilia A Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Hemophilia A Drug Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Hemophilia A Drug Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Hemophilia A Drug Price (USD/Pcs) by Type (2013-2018)

3 HEMOPHILIA A DRUG APPLICATION/END USERS

3.1 Hemophilia A Drug Segment by Application/End Users
  3.1.1 Clinic
  3.1.2 Hospital
  3.1.3 ASCs
3.2 Global Hemophilia A Drug Product Segment by Application
  3.2.1 Global Hemophilia A Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Hemophilia A Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Hemophilia A Drug Product Segment by Application
  3.3.1 United States Hemophilia A Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Hemophilia A Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 HEMOPHILIA A DRUG MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Hemophilia A Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Hemophilia A Drug Sales and Revenue by Regions
  4.2.1 Global Hemophilia A Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Hemophilia A Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL HEMOPHILIA A DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Hemophilia A Drug Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Hemophilia A Drug Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Hemophilia A Drug Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Hemophilia A Drug Manufacturing Base Distribution, Sales Area, Product Types
5.5 Hemophilia A Drug Market Competitive Situation and Trends
  5.5.1 Hemophilia A Drug Market Concentration Rate
  5.5.2 Global Hemophilia A Drug Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES HEMOPHILIA A DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Hemophilia A Drug Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Hemophilia A Drug Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Hemophilia A Drug Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Hemophilia A Drug Market Share (%) of Top 3 and Top 5 Players

7 HEMOPHILIA A DRUG PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Bayer AG
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Hemophilia A Drug Product Category, Application and Specification
   7.1.2.1 Product A
   7.1.2.2 Product B
  7.1.3 Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 BioMarin Pharmaceutical Inc
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Hemophilia A Drug Product Category, Application and Specification
   7.2.2.1 Product A
   7.2.2.2 Product B
  7.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Bioverativ Inc
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Hemophilia A Drug Product Category, Application and Specification
   7.3.2.1 Product A
   7.3.2.2 Product B
  7.3.3 Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Catalyst Biosciences Inc
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Hemophilia A Drug Product Category, Application and Specification
   7.4.2.1 Product A
   7.4.2.2 Product B
  7.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Chugai Pharmaceutical Co Ltd
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Hemophilia A Drug Product Category, Application and Specification
   7.5.2.1 Product A
   7.5.2.2 Product B
  7.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 CSL Ltd
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Hemophilia A Drug Product Category, Application and Specification
   7.6.2.1 Product A
   7.6.2.2 Product B
  7.6.3 CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 DBV Technologies SA
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Hemophilia A Drug Product Category, Application and Specification
   7.7.2.1 Product A
   7.7.2.2 Product B
  7.7.3 DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Dimension Therapeutics Inc
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Hemophilia A Drug Product Category, Application and Specification
   7.8.2.1 Product A
   7.8.2.2 Product B
  7.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 EpiVax Inc
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Hemophilia A Drug Product Category, Application and Specification
   7.9.2.1 Product A
   7.9.2.2 Product B
  7.9.3 EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Expression Therapeutics LLC
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Hemophilia A Drug Product Category, Application and Specification
   7.10.2.1 Product A
   7.10.2.2 Product B
  7.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Green Cross Corp
7.12 Idogen AB
7.13 Immusoft Corp
7.14 LFB SA
7.15 mAbxience SA

8 HEMOPHILIA A DRUG MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Hemophilia A Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Hemophilia A Drug Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL HEMOPHILIA A DRUG MARKET FORECAST

10.1 Global Hemophilia A Drug Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.2 Global Hemophilia A Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Hemophilia A Drug Market Forecast
  10.2.1 United States Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Hemophilia A Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Hemophilia A Drug Forecast by Regions
  10.3.1 North America Hemophilia A Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Hemophilia A Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Hemophilia A Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Hemophilia A Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Hemophilia A Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Hemophilia A Drug Forecast by Type
  10.4.1 Global Hemophilia A Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Hemophilia A Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Hemophilia A Drug Forecast by Application
  10.5.1 Global Hemophilia A Drug Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Hemophilia A Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION



The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Hemophilia A Drug Product Picture
Figure Global Hemophilia A Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Hemophilia A Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of ATXF-8117
Table Major Players of ATXF-8117
Figure Global ATXF-8117 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of BAY-1093884
Table Major Players of BAY-1093884
Figure Global BAY-1093884 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of BIVV-001
Table Major Players of BIVV-001
Figure Global BIVV-001 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of BS-027125
Table Major Players of BS-027125
Figure Global BS-027125 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Concizumab
Table Major Players of Concizumab
Figure Global Concizumab Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of CSL-689
Table Major Players of CSL-689
Figure Global CSL-689 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Hemophilia A Drug Sales (K Pcs) by Type (2013-2018)
Table Global Hemophilia A Drug Sales Share (%) by Type (2013-2018)
Figure Global Hemophilia A Drug Sales Market Share (%) by Type (2013-2018)
Figure Global Hemophilia A Drug Sales Market Share (%) by Type in 2017
Table Global Hemophilia A Drug Revenue (Million USD) by Type (2013-2018)
Table Global Hemophilia A Drug Revenue Share (%) by Type (2013-2018)
Figure Global Hemophilia A Drug Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Hemophilia A Drug Revenue Market Share (%) by Type
Table Global Hemophilia A Drug Price (USD/Pcs) by Type (2013-2018)
Table United States Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Hemophilia A Drug Sales (K Pcs) by Type (2013-2018)
Table United States Hemophilia A Drug Sales Share (%) by Type (2013-2018)
Figure United States Hemophilia A Drug Sales Market Share (%) by Type (2013-2018)
Figure United States Hemophilia A Drug Sales Market Share (%) by Type in 2017
Table United States Hemophilia A Drug Revenue (Million USD) by Type (2013-2018)
Table United States Hemophilia A Drug Revenue Share (%) by Type (2013-2018)
Figure United States Hemophilia A Drug Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Hemophilia A Drug Revenue Market Share (%) by Type
Table United States Hemophilia A Drug Price (USD/Pcs) by Type (2013-2018)
Figure Clinic Examples
Figure Hospital Examples
Figure ASCs Examples
Table Global Hemophilia A Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Hemophilia A Drug Sales (K Pcs) by Application (2013-2018)
Table Global Hemophilia A Drug Sales Share (%) by Application (2013-2018)
Figure Global Hemophilia A Drug Sales Market Share (%) by Application (2013-2018)
Figure Global Hemophilia A Drug Sales Market Share (%) by Application in 2017
Table United States Hemophilia A Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Hemophilia A Drug Sales (K Pcs) by Application (2013-2018)
Table United States Hemophilia A Drug Sales Share (%) by Application (2013-2018)
Figure United States Hemophilia A Drug Sales Market Share (%) by Application (2013-2018)
Figure United States Hemophilia A Drug Sales Market Share (%) by Application in 2017
Table Global Hemophilia A Drug Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Hemophilia A Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Hemophilia A Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Hemophilia A Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Hemophilia A Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Hemophilia A Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Hemophilia A Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Hemophilia A Drug Sales (K Pcs) by Regions (2013-2018)
Table Global Hemophilia A Drug Sales Market Share (%) by Regions (2013-2018)
Figure Global Hemophilia A Drug Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Hemophilia A Drug Sales Market Share (%) by Regions
Figure 2017 United States Hemophilia A Drug Sales Market Share (%) in Global Market
Table Global Hemophilia A Drug Revenue (Million USD) by Regions (2013-2018)
Table Global Hemophilia A Drug Revenue Market Share (%) by Regions (2013-2018)
Figure Global Hemophilia A Drug Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Hemophilia A Drug Revenue Market Share (%) by Regions
Figure 2017 United States Hemophilia A Drug Revenue Market Share (%) in Global Market
Table Global Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Hemophilia A Drug Sales (K Pcs) of Key Players (2013-2018)
Table Global Hemophilia A Drug Sales Share (%) by Players (2013-2018)
Figure 2017 Global Hemophilia A Drug Sales Share (%) by Players
Figure 2018 Global Hemophilia A Drug Sales Share (%) by Players
Table Global Hemophilia A Drug Revenue (Million USD) by Players (2013-2018)
Table Global Hemophilia A Drug Revenue Share (%) by Players (2013-2018)
Table 2017 Global Hemophilia A Drug Revenue Share (%) by Players
Table 2018 Global Hemophilia A Drug Revenue Share (%) by Players
Table Global Market Hemophilia A Drug Average Price (USD/Pcs) by Players (2013-2018)
Table Global Hemophilia A Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Hemophilia A Drug Top Players Product Category
Figure Global Hemophilia A Drug Market Share (%) of Top 3 Players
Figure Global Hemophilia A Drug Market Share (%) of Top 5 Players
Table United States Hemophilia A Drug Sales (K Pcs) by Players (2013-2018)
Table United States Hemophilia A Drug Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Hemophilia A Drug Sales Share (%) by Players
Figure 2018 United States Hemophilia A Drug Sales Share (%) by Players
Table United States Hemophilia A Drug Revenue (Million USD) by Players (2013-2018)
Table United States Hemophilia A Drug Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Hemophilia A Drug Revenue Share (%) by Players
Table 2018 United States Hemophilia A Drug Revenue Share (%) by Players
Table United States Market Hemophilia A Drug Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Hemophilia A Drug Market Share (%) of Top 3 Players
Figure United States Hemophilia A Drug Market Share (%) of Top 5 Players
Table Bayer AG Basic Information List
Table Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bayer AG Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure Bayer AG Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure Bayer AG Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table BioMarin Pharmaceutical Inc Basic Information List
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table Bioverativ Inc Basic Information List
Table Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bioverativ Inc Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure Bioverativ Inc Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure Bioverativ Inc Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table Catalyst Biosciences Inc Basic Information List
Table Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Catalyst Biosciences Inc Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure Catalyst Biosciences Inc Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure Catalyst Biosciences Inc Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table Chugai Pharmaceutical Co Ltd Basic Information List
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table CSL Ltd Basic Information List
Table CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure CSL Ltd Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure CSL Ltd Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure CSL Ltd Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table DBV Technologies SA Basic Information List
Table DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure DBV Technologies SA Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure DBV Technologies SA Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure DBV Technologies SA Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table Dimension Therapeutics Inc Basic Information List
Table Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Dimension Therapeutics Inc Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure Dimension Therapeutics Inc Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure Dimension Therapeutics Inc Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table EpiVax Inc Basic Information List
Table EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure EpiVax Inc Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure EpiVax Inc Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure EpiVax Inc Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table Expression Therapeutics LLC Basic Information List
Table Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Expression Therapeutics LLC Hemophilia A Drug Sales Growth Rate (2013-2018)
Figure Expression Therapeutics LLC Hemophilia A Drug Sales Global Market Share (%)(2013-2018)
Figure Expression Therapeutics LLC Hemophilia A Drug Revenue Global Market Share (%)(2013-2018)
Table Green Cross Corp Basic Information List
Table Idogen AB Basic Information List
Table Immusoft Corp Basic Information List
Table LFB SA Basic Information List
Table mAbxience SA Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia A Drug
Figure Hemophilia A Drug Industrial Chain Analysis
Table Major Buyers of Hemophilia A Drug
Table Distributors/Traders List
Figure Global Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Hemophilia A Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Hemophilia A DrugHemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Hemophilia A Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Hemophilia A Drug Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Hemophilia A Drug Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Hemophilia A Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Hemophilia A Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Hemophilia A Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Hemophilia A Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Hemophilia A Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Hemophilia A Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Hemophilia A Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Hemophilia A Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Hemophilia A Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Hemophilia A Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Hemophilia A Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Hemophilia A Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Hemophilia A Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Hemophilia A Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Hemophilia A Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Hemophilia A Drug Sales Forecast by Application (2018-2025)
Table United States Hemophilia A Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Hemophilia A Drug Sales Forecast by Application (2018-2025)